HVC
AEGR

Healthcare Value Capital’s Aegerion Pharmaceuticals AEGR Stock Holding History

Healthcare Value Capital’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50,000
Closed -$680K – 30
2015
Q3 		$680K Sell
50,000
-30,000
-38% -$534K 0.97% 19
2015
Q2 		$1.52M Buy
80,000
+55,000
+220% +$1.19M 1.59% 17
2015
Q1 		$654K Buy
+25,000
New +$636K 0.71% 26

Other funds holding AEGR

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare Value Capital's AEGR Position: Q4 2015 in Review

Healthcare Value Capital sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2015, closing a stake of 50,000 shares — an estimated $680K sold.

Healthcare Value Capital first reported a position in AEGR in Q1 2015 and held it in 3 quarters. The position peaked at $1.52M in Q2 2015. 109 funds tracked by Wall St. Rank hold AEGR as of Q4 2015.

  • Healthcare Value Capital reported no remaining Aegerion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Healthcare Value Capital sold 50,000 Aegerion Pharmaceuticals shares in Q4 2015, an estimated $680K.
  • Healthcare Value Capital first reported a position in Aegerion Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Healthcare Value Capital's Aegerion Pharmaceuticals position peaked at $1.52M in Q2 2015.
  • 109 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2015.

Based on Healthcare Value Capital's 13F filing for Q4 2015, filed 16 Feb 2016.